Literature DB >> 25985248

Short- and Long-Term Outcomes of Acute Severe Ulcerative Colitis in Korea: The 1999-2005 Cohort.

Ho-Su Lee1, Suk-Kyun Yang, Jae Seung Soh, Seohyun Lee, Jung Ho Bae, Hyo Jeong Lee, Sang Hyoung Park, Dong-Hoon Yang, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Yong Sik Yoon, Chang Sik Yu, Jin-Ho Kim.   

Abstract

BACKGROUND: No previous studies have evaluated the long-term outcomes of acute severe ulcerative colitis (ASUC) in non-Caucasian populations. The purposes of this study were to evaluate the short- and long-term outcomes of Korean patients with ASUC.
METHODS: We retrospectively analyzed 99 Korean patients with ASUC who satisfied the criteria given by Truelove and Witts between 1999 and 2005. The short-term outcome parameter was the colectomy rate during index hospitalization, and the long-term outcome parameters were the rates of colectomy and rehospitalization after discharge from index hospitalization.
RESULTS: During index hospitalization, 16 of 99 patients (16.2%) underwent colectomy: 6 of 71 responders (8.5%) to intravenous steroids on day 3 versus 10 of 28 nonresponders (35.7%), as assessed using the Oxford index (P = 0.002). Among 83 patients who avoided colectomy during index hospitalization, 13 patients (15.7%) underwent colectomy during the median follow-up period of 10.6 years. The cumulative probability of colectomy tended to be lower in complete responders on day 7 of intravenous steroid therapy (CR7) than in others: 3.7% versus 13.9% at 5 years and 7.6% versus 18.2% at 10 years (P = 0.100). The cumulative probability of rehospitalization was significantly lower in CR7 than in other patients: 20.5% versus 37.5% at 5 years and 31.4% versus 48.2% at 10 years (P = 0.043).
CONCLUSIONS: Assessing the degree of response to intravenous steroids helps predict the short- and long-term outcomes in patients with ASUC. Korean patients with ASUC may have better clinical courses than Caucasians, as indicated by the lower colectomy rate.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25985248     DOI: 10.1097/MIB.0000000000000447

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

1.  Long-Term Outcomes of Immunosuppression-Naïve Steroid Responders Following Hospitalization for Ulcerative Colitis.

Authors:  Amar Vedamurthy; Louise Xu; Jay Luther; Francis Colizzo; John J Garber; Hamed Khalili; Ashwin N Ananthakrishnan
Journal:  Dig Dis Sci       Date:  2018-06-27       Impact factor: 3.199

2.  Rate and Predictors of Mucosal Healing in Ulcerative Colitis Treated with Thiopurines: Results of a Multicentric Cohort Study.

Authors:  Caroline Prieux-Klotz; Stéphane Nahon; Aurelien Amiot; Leila Sinayoko; Carole Galéano-Cassaz; Stanislas Chaussade; Romain Coriat; Pierre Lahmek; Vered Abitbol
Journal:  Dig Dis Sci       Date:  2016-11-16       Impact factor: 3.199

Review 3.  Epidemiology of Inflammatory Bowel Disease in India: The Great Shift East.

Authors:  Saurabh Kedia; Vineet Ahuja
Journal:  Inflamm Intest Dis       Date:  2017-04-08

4.  A Microsimulation Model to Project the 5-Year Impact of Using Hyperbaric Oxygen Therapy for Ulcerative Colitis Patients Hospitalized for Acute Flares.

Authors:  Parambir S Dulai; Vipul Jairath
Journal:  Dig Dis Sci       Date:  2020-11-13       Impact factor: 3.487

5.  A retrospective analysis of 20-year data of the surgical management of ulcerative colitis patients in Taiwan: a study of Taiwan Society of Inflammatory Bowel Disease.

Authors:  Chun-Chi Lin; Shu-Chen Wei; Been-Ren Lin; Wen-Sy Tsai; Jinn-Shiun Chen; Tzu-Chi Hsu; Wei-Chen Lin; Tien-Yu Huang; Te-Hsin Chao; Hung-Hsin Lin; Jau-Min Wong; Jen-Kou Lin
Journal:  Intest Res       Date:  2016-06-27

Review 6.  How Does the Epidemiology of Inflammatory Bowel Disease Differ between East and West? A Korean Perspective.

Authors:  Suk-Kyun Yang
Journal:  Inflamm Intest Dis       Date:  2017-01-14

7.  Left-sided colitis and extensive colitis have similar colectomy rates after index episode of acute severe colitis: A long-term follow-up study.

Authors:  Saransh Jain; Saurabh Kedia; Sawan Bopanna; Dawesh P Yadav; Sandeep Goyal; Peush Sahni; Nihar R Dash; Sujoy Pal; Govind Makharia; Vineet Ahuja
Journal:  JGH Open       Date:  2017-11-28

8.  Long-term outcomes of infliximab in a real-world multicenter cohort of patients with acute severe ulcerative colitis.

Authors:  Shin Ju Oh; Ga Young Shin; Hosim Soh; Jae Gon Lee; Jong Pil Im; Chang Soo Eun; Kang-Moon Lee; Dong Il Park; Dong Soo Han; Hyo Jong Kim; Chang Kyun Lee
Journal:  Intest Res       Date:  2020-08-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.